Table III.
Comparison of cardiovascular risk between the two groups.
| Framingham score | PROCAM score | ATPIII score | ||||
|---|---|---|---|---|---|---|
| Risk of cardiovascular events within 10 years | NAFLD group | Simple CHD group | NAFLD group | Simple CHD group | NAFLD group | Simple CHD group |
| Median, %(IQR) | 1.2 (5.1) | 3.7 (6.7) | 0.5 (1.1) | 0.8 (2.2) | <1.0 (2.5) | 1.5 (4.0) |
| <1% | 43 | 13 | 57 | 37 | 54 | 29 |
| 1–3% | 21 | 42 | 36 | 33 | 25 | 40 |
| 4–6% | 18 | 12 | 013 | 14 | 11 | |
| 7–10% | 7 | 23 | 74 | 7 | 10 | |
| >10% | 11 | 10 | 013 | 0 | 10 | |
| P-value | 0.017 | 0.045 | 0.129 | |||
IQR and percentage of each risk are used for data in both groups. IQR, interquartile range; NAFLD, non-alcoholic fatty liver disease; CHD, coronary heart disease; PROCAM, prospective cardiovascular Munster; ATPIII, Adult Treatment Expert Panel III.